首页 > 最新文献

Proceedings of the Clinical Dialysis and Transplant Forum最新文献

英文 中文
Hemodialysis access site morbidity. 血液透析通路发病率。
L C Aman, N W Levin, D W Smith
{"title":"Hemodialysis access site morbidity.","authors":"L C Aman, N W Levin, D W Smith","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76353,"journal":{"name":"Proceedings of the Clinical Dialysis and Transplant Forum","volume":"10 ","pages":"277-84"},"PeriodicalIF":0.0,"publicationDate":"1980-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18358486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of the Emergency Medical Services in organ donation. 紧急医疗服务在器官捐赠方面的角色。
F C Whittier, D R Boyd, J Warren

A potential need for more organ donors has been identified because of the improved survival rates of patients receiving kidney transplants and the reports of improving graft success rates. Because of the development of the EMS trauma program, an awareness of the potential benefit for increased organ donation could be realized by improved working relationship of the EMS trauma unit and the organ recovery agency. In the final analysis, careful planning of a regionwide program for organ recovery by the organ retrieval groups to include the EMS trauma unit should result in an increased number of cadaveric kidneys for transplantation.

由于接受肾脏移植的患者存活率的提高和移植成功率的提高,已经确定了对更多器官供体的潜在需求。由于EMS创伤项目的发展,通过改善EMS创伤单位和器官恢复机构的工作关系,可以意识到增加器官捐赠的潜在好处。在最后的分析中,由器官回收组(包括EMS创伤组)精心规划的器官恢复区域性计划应该会增加用于移植的尸体肾脏的数量。
{"title":"The role of the Emergency Medical Services in organ donation.","authors":"F C Whittier,&nbsp;D R Boyd,&nbsp;J Warren","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A potential need for more organ donors has been identified because of the improved survival rates of patients receiving kidney transplants and the reports of improving graft success rates. Because of the development of the EMS trauma program, an awareness of the potential benefit for increased organ donation could be realized by improved working relationship of the EMS trauma unit and the organ recovery agency. In the final analysis, careful planning of a regionwide program for organ recovery by the organ retrieval groups to include the EMS trauma unit should result in an increased number of cadaveric kidneys for transplantation.</p>","PeriodicalId":76353,"journal":{"name":"Proceedings of the Clinical Dialysis and Transplant Forum","volume":"10 ","pages":"155-9"},"PeriodicalIF":0.0,"publicationDate":"1980-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18098546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dialyzer reuse: a long-term study of safety and efficacy at one center. 透析器再利用:一个中心的安全性和有效性的长期研究。
K S Kant, V E Pollak, D Goetz, M Cathey
{"title":"Dialyzer reuse: a long-term study of safety and efficacy at one center.","authors":"K S Kant,&nbsp;V E Pollak,&nbsp;D Goetz,&nbsp;M Cathey","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76353,"journal":{"name":"Proceedings of the Clinical Dialysis and Transplant Forum","volume":"10 ","pages":"35-8"},"PeriodicalIF":0.0,"publicationDate":"1980-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17862327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A double-blind controlled trial of acetate versus bicarbonate dialysate. 醋酸盐与碳酸氢盐透析液的双盲对照试验。
P R Uldall, I Kennedy, H Craske, E Porrett, J Aid, F Woods, D Levine

A controlled, cross-over trial of bicarbonate versus acetate hemodialysis over a 24 wk period in 16 patients with end-stage renal failure has shown a significantly lower incidence of dialysis-related symptoms during dialysis with bicarbonate. The level of well-being in the intervals between dialysis was not appreciably affected by the dialysis mode. It is suggested that bicarbonate dialysis should be made available to all patients receiving regular hemodialysis for end-stage renal failure provided that this can be done reliably and safely.

一项对16例终末期肾衰竭患者进行24周碳酸氢盐与醋酸盐血液透析的对照交叉试验显示,碳酸氢盐透析期间透析相关症状的发生率显著降低。在透析间隔期间的健康水平不受透析模式的明显影响。建议在可靠和安全的条件下,所有接受定期血液透析的终末期肾衰竭患者都应接受碳酸氢盐透析。
{"title":"A double-blind controlled trial of acetate versus bicarbonate dialysate.","authors":"P R Uldall,&nbsp;I Kennedy,&nbsp;H Craske,&nbsp;E Porrett,&nbsp;J Aid,&nbsp;F Woods,&nbsp;D Levine","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A controlled, cross-over trial of bicarbonate versus acetate hemodialysis over a 24 wk period in 16 patients with end-stage renal failure has shown a significantly lower incidence of dialysis-related symptoms during dialysis with bicarbonate. The level of well-being in the intervals between dialysis was not appreciably affected by the dialysis mode. It is suggested that bicarbonate dialysis should be made available to all patients receiving regular hemodialysis for end-stage renal failure provided that this can be done reliably and safely.</p>","PeriodicalId":76353,"journal":{"name":"Proceedings of the Clinical Dialysis and Transplant Forum","volume":"10 ","pages":"220-3"},"PeriodicalIF":0.0,"publicationDate":"1980-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18097346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improved results in high risk cadaveric kidney transplantation. 改善高危尸体肾移植的结果。
L H Toledo-Pereyra, S Baskin, L McNichol, G Edford, J Whitten, R Allaben

In general, cadaver kidney transplantation survival remains at 40-50% for the first year after transplantation. To compare the beneficial effect of a new immunosuppressive protocol to standard therapy (azathioprine and prednisone), we have studied 30 high risk first cadaveric renal allograft recipients who were randomly selected before (Group A, n=15) and after (Group B, n=15) 10/79. At 12 mos, actuarial graft survival of Group B is 75% compared to 46% in Group A. Actuarial patient survival for Group B is 94% for one year compared to 60% in Group A. We feel that these improved results are related to basic changes in our immunosuppressive protocol. These changes consist of: 1. Low doses of azathioprine and prednisolone (less than 1 mg/kg) with rapid reduction to very low levels (less than 0.3 mg/kg); 2. ALG administration at 30 mg/kg/day for 14 times; 3. Rapid placement (one month) on alternate day steroid therapy; 4. Elimination of steroids for the treatment of rejection; 5. Use of ALG (20 mg/kg/day for 10 days) for the treatment of rejection; 6. Use of ALG combined with modified lymph node irradiation for third rejection episodes; and 7. Long-term intermittent ALG administration provided that kidney function continues to be normal. The best immunosuppressive protocol is clearly the one associated with less morbidity and improved quality of life after transplantation. Our current protocol (Group B) provides the best results.

一般来说,尸体肾移植后第一年的存活率保持在40-50%。为了比较一种新的免疫抑制方案与标准治疗(硫唑嘌呤和泼尼松)的有益效果,我们研究了30例高风险首次尸体肾移植受体,随机选择10/79术前(a组,n=15)和术后(B组,n=15)。在12个月时,B组的精算移植存活率为75%,而a组为46%。B组的精算患者一年存活率为94%,而a组为60%。我们认为这些改善的结果与我们免疫抑制方案的基本改变有关。这些变化包括:1。低剂量硫唑嘌呤和强的松龙(低于1mg /kg),并迅速降至极低水平(低于0.3 mg/kg);2. ALG给药30 mg/kg/天,连用14次;3.快速放置(一个月)隔天类固醇治疗;4. 停止使用类固醇治疗排斥反应;5. 使用ALG (20 mg/kg/天,连用10天)治疗排斥反应;6. ALG联合改良淋巴结放疗治疗第三次排斥反应和7。在肾功能持续正常的情况下,长期间歇性给予ALG。最好的免疫抑制方案显然是与低发病率和改善移植后生活质量相关的方案。我们目前的方案(B组)提供了最好的效果。
{"title":"Improved results in high risk cadaveric kidney transplantation.","authors":"L H Toledo-Pereyra,&nbsp;S Baskin,&nbsp;L McNichol,&nbsp;G Edford,&nbsp;J Whitten,&nbsp;R Allaben","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In general, cadaver kidney transplantation survival remains at 40-50% for the first year after transplantation. To compare the beneficial effect of a new immunosuppressive protocol to standard therapy (azathioprine and prednisone), we have studied 30 high risk first cadaveric renal allograft recipients who were randomly selected before (Group A, n=15) and after (Group B, n=15) 10/79. At 12 mos, actuarial graft survival of Group B is 75% compared to 46% in Group A. Actuarial patient survival for Group B is 94% for one year compared to 60% in Group A. We feel that these improved results are related to basic changes in our immunosuppressive protocol. These changes consist of: 1. Low doses of azathioprine and prednisolone (less than 1 mg/kg) with rapid reduction to very low levels (less than 0.3 mg/kg); 2. ALG administration at 30 mg/kg/day for 14 times; 3. Rapid placement (one month) on alternate day steroid therapy; 4. Elimination of steroids for the treatment of rejection; 5. Use of ALG (20 mg/kg/day for 10 days) for the treatment of rejection; 6. Use of ALG combined with modified lymph node irradiation for third rejection episodes; and 7. Long-term intermittent ALG administration provided that kidney function continues to be normal. The best immunosuppressive protocol is clearly the one associated with less morbidity and improved quality of life after transplantation. Our current protocol (Group B) provides the best results.</p>","PeriodicalId":76353,"journal":{"name":"Proceedings of the Clinical Dialysis and Transplant Forum","volume":"10 ","pages":"289-92"},"PeriodicalIF":0.0,"publicationDate":"1980-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18097353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An analysis of factors influencing the growth of children after renal transplantation. 影响儿童肾移植后生长发育的因素分析。
J K Hurley, T Greenslade, J S Chmiel
{"title":"An analysis of factors influencing the growth of children after renal transplantation.","authors":"J K Hurley,&nbsp;T Greenslade,&nbsp;J S Chmiel","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76353,"journal":{"name":"Proceedings of the Clinical Dialysis and Transplant Forum","volume":"10 ","pages":"293-5"},"PeriodicalIF":0.0,"publicationDate":"1980-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18097354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The organization of a successful donor-specific transfusion protocol in related recipients with high MLC. 在相关高MLC受者中成功组织供者特异性输血方案。
S Hopper, N Feduska, F Vincenti, W Amend, O Salvatierra
{"title":"The organization of a successful donor-specific transfusion protocol in related recipients with high MLC.","authors":"S Hopper,&nbsp;N Feduska,&nbsp;F Vincenti,&nbsp;W Amend,&nbsp;O Salvatierra","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76353,"journal":{"name":"Proceedings of the Clinical Dialysis and Transplant Forum","volume":"10 ","pages":"272-6"},"PeriodicalIF":0.0,"publicationDate":"1980-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17244897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preliminary clinical results with sodium-volume modeling of hemodialysis therapy. 初步临床结果与钠容量模型血液透析治疗。
F A Gotch, M A Lam, M Prowitt, M Keen
{"title":"Preliminary clinical results with sodium-volume modeling of hemodialysis therapy.","authors":"F A Gotch,&nbsp;M A Lam,&nbsp;M Prowitt,&nbsp;M Keen","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76353,"journal":{"name":"Proceedings of the Clinical Dialysis and Transplant Forum","volume":"10 ","pages":"12-7"},"PeriodicalIF":0.0,"publicationDate":"1980-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18358479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody. 无乙型肝炎表面抗原或抗体的透析患者的乙型肝炎标志物。
T J Kelly, T V Sanchez, M J Patterson, G H Mayor
{"title":"Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.","authors":"T J Kelly,&nbsp;T V Sanchez,&nbsp;M J Patterson,&nbsp;G H Mayor","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76353,"journal":{"name":"Proceedings of the Clinical Dialysis and Transplant Forum","volume":"10 ","pages":"165-8"},"PeriodicalIF":0.0,"publicationDate":"1980-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18358480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of zinc therapy on uremic hypogonadism: a double blind study. 锌治疗尿毒症性性腺功能减退的双盲研究。
S K Mahajan, A A Abbasi, A S Prasad, W A Briggs, F D McDonald
{"title":"Effect of zinc therapy on uremic hypogonadism: a double blind study.","authors":"S K Mahajan,&nbsp;A A Abbasi,&nbsp;A S Prasad,&nbsp;W A Briggs,&nbsp;F D McDonald","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76353,"journal":{"name":"Proceedings of the Clinical Dialysis and Transplant Forum","volume":"9 ","pages":"260-1"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11341487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Proceedings of the Clinical Dialysis and Transplant Forum
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1